incretin mimetics glp 1 agonists GLP-1s & Beyond: Understanding Mimetic Opportunities PDB-101: Diabetes Mellitus: Diabetes Mellitus:
Description
Reduced Stability and PH-Dependent Activity of a Common Obesity-Linked PCSK1 Polymorphism, N221D. Endocrinology, vol
Steensgaard, D.B., Thomsen, J.K., Strauss, H., Normann, M., Ludvigsen, S
Both protein intake and the maintenance of muscle mass through diet and exercise are important for preserving overall metabolic rate and health
Critics also highlight that brand-name GLP-1 manufacturers have secured extensive patent protection, averaging 19.5 patents per drug and 18.3 years of expected exclusivity, with over half of these patents focused on delivery devices rather than the drugs themselves [71]
